7-Amino-3,3-dimethylindolin-2-one

ID: ALA4847005

PubChem CID: 131839717

Max Phase: Preclinical

Molecular Formula: C10H12N2O

Molecular Weight: 176.22

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1(C)C(=O)Nc2c(N)cccc21

Standard InChI:  InChI=1S/C10H12N2O/c1-10(2)6-4-3-5-7(11)8(6)12-9(10)13/h3-5H,11H2,1-2H3,(H,12,13)

Standard InChI Key:  KRKXEHWYUYXQDH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 13 14  0  0  0  0  0  0  0  0999 V2000
   13.1824   -4.3377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6046   -3.7599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3931   -4.5492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4033   -2.6909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4022   -3.5105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1102   -3.9194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1084   -2.2821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8171   -2.6873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8219   -3.5105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0863   -3.0915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5984   -2.4284    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9034   -3.0866    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1060   -1.4649    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9  2  1  0
  2 10  1  0
 10 11  1  0
 11  8  1  0
 10 12  2  0
  7 13  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4847005

    ---

Associated Targets(Human)

PDK2 Tchem Pyruvate dehydrogenase kinase isoform 2 (894 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDK4 Tchem Pyruvate dehydrogenase kinase isoform 4 (177 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 176.22Molecular Weight (Monoisotopic): 176.0950AlogP: 1.50#Rotatable Bonds:
Polar Surface Area: 55.12Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.12CX Basic pKa: 3.25CX LogP: 1.34CX LogD: 1.34
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.59Np Likeness Score: 0.30

References

1. Akaki T, Bessho Y, Ito T, Fujioka S, Ubukata M, Mori G, Yamanaka K, Orita T, Doi S, Iwanaga T, Ikegashira K, Hantani Y, Nakanishi I, Adachi T..  (2021)  Fragment-based lead discovery to identify novel inhibitors that target the ATP binding site of pyruvate dehydrogenase kinases.,  44  [PMID:34274549] [10.1016/j.bmc.2021.116283]

Source